C12Y 208/02029
[heparan sulfate]-glucosamine 3-sulfotransferase 2
Official title: [Heparan sulfate]-glucosamine 3-sulfotransferase 2 (2.8.2.29)
C12Y208/02029 ([heparan sulfate]-glucosamine 3-sulfotransferase 2) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 5
- Assignees
- 10
- Inventors
- 10
- Latest grant
- 18 Jun 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Biomolecular condensate manufacturing scaffold5 Dec 2024US 2024/0401096 A1Celvant LLC
- Method of diagnosis, prognosis or treatment of neurodegenerative diseases21 Jan 2021US 2021/0018518 A1Assistance Publique-Hopitaux de Paris
- Method of diagnosis, prognosis or treatment of neurodegenerative diseases15 Feb 2018US 2018/0045740 A1Assistance Publique-Hopitaux de Paris
- Method of diagnosis, prognostic or treatment of neurodegenerative diseases17 Nov 2016US 2016/0334421 A1Assistance Publique-Hopitaux de Paris
- Method of diagnosis, prognostic or treatment of neurodegenerative diseases9 Oct 2014US 2014/0302510 A1Assistance Publique-Hopitaux Paris
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.